New hope for Australian leukaemia and lymphoma patients
A key new cancer treatment has just become more accessible for Australians fighting specific forms of leukaemia and lymphoma Federal Member for Page Kevin Hogan said the Federal Government has listed Calquence® on the Pharmaceutical Benefits Scheme (PBS). Calquence® (acalabrutinib) has been listed on the PBS for the first time for the treatment…
